United States:
FDA Issues Final Order Downclassifying Certain IVDs
To print this article, all you need is to be registered or login on Mondaq.com.
In the May 30 Federal Register, FDA issued a final order
reclassifying nucleic acid-based in vitro diagnostic
("IVD") devices for the detection of Mycobacterium
tuberculosis complex in respiratory specimens from class III into
class II. This rule is effective June 30.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...